NEI Keynote Speaker
Dr. Creig Hoyt, pediatric and neuro-ophthalmologist Creig Hoyt, MD, MA, was keynote speaker at the recent National Eye Institute conference sponsored by the Lasker Foundation and held at the Howard Hughes Medical Institute research campus in Virginia. Dr. Hoyt spoke on amblyopia, a developmental disorder of the eye that generally begins in early childhood. Amblyopia is the medical term used when vision in one eye is reduced because the eye and brain are not working together properly.
Dr. Hoyt is best known for a breakthrough in the treatment of congenital cataracts, which permanently impair vision if not removed during infancy. His landmark study improved treatment worldwide by demonstrating that cataracts can be removed safely from the eyes of very young infant.
Global Education Award – Dr. Richard Abbott
The International Council of Ophthalmology recently presented UCSF cornea specialist Richard Abbott, MD, with its Mark Tso Golden Apple Award at the opening ceremony of the World Ophthalmology Congress in Guadelajara, Mexico.
The World Health Organization has identified medical error as a major problem for all countries and referred to it as a global issue of epidemic proportions. Dr. Abbott discussed initiatives for improving patient safety and offered concrete initiatives to better patient outcomes.
Michele Bloomer, MD
Invited Lecturer and Co-Chair: Cataract-Ophthalmic Resident Education West, San Diego. This two-day cataract surgery training instructs ophthalmology residents from programs throughout the United States and Puerto Rico.
David R. Copenhagen, PhD
Invited Lecturer: Photoreception in Fetal & Newborn Mice: Actions on Behavior and Vascular Patterning in the Eye. Grand Rounds, University of Utah.
David Hwang, MD, FACS
Honor: Awarded the Pearl T. Kimura and Samuel J. Kimura Endowed Chair in Ophthalmology
Shan Lin, MD
Publication: Wang YE, Kakigi C, Barbosa D, Porco T, Chen R,Wang S, Li Y, Singh K, Pasquale LR,
Lin SC. Oral contraceptive use and prevalence of self-reported glaucoma or ocular hypertension in the United States. Ophthalmology. 2016 Apr;123(4):729-36. doi: 10.1016/j.ophtha.2015.11.029. Epub 2016 Feb 11.
Dr. Lin and his team found that women who took oral contraceptives for three years or longer had a higher risk for self-reporting glaucoma in a U.S. population-based study. These findings support that the natural cycle of estrogen production (which is suppressed by contraceptives) may be protective against glaucoma development.